These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 5736091

  • 1. [Clinical and biochemical study of a new uricosuric: benziodarone].
    Rapado A, Llamazares C.
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):249-51. PubMed ID: 5736091
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical and biological action of a new hypouricemiant (benziodarone) in gout. Results of 2 years of experience].
    Santamaría A, Barceló P.
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):252-63. PubMed ID: 4899417
    [No Abstract] [Full Text] [Related]

  • 3. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP.
    Munch Med Wochenschr; 1969 Feb 28; 111(9):491-5. PubMed ID: 5818966
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Benziodarone in gout therapy].
    Ryckewaert A, Kuntz D.
    Therapeutique; 1970 Dec 28; 46(10):989-91. PubMed ID: 5511935
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of hyperuricemia with benziodarone].
    Ravault PP, Vignon G, Lejeune E, Bouvier M, Queneau P.
    Presse Therm Clim; 1970 Dec 28; 107(2):74-9. PubMed ID: 5468122
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of hyperuricemia in gout and renal insufficiency with benziodarone].
    Richet G, Cottet J, Amiel C, Leroux-Robert C, Podevin R.
    Presse Med (1893); 1966 May 14; 74(24):1247-9. PubMed ID: 5936081
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Value of a pharmaceutic preparation combining benziodarone with an alkalinizator for the treatment of gout].
    André LJ, Delprat J.
    Sem Hop Ther; 1974 May 14; 50(5-6):376-80. PubMed ID: 4612715
    [No Abstract] [Full Text] [Related]

  • 17. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A.
    Rein Foie; 1967 May 14; 10():273-92. PubMed ID: 6081455
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Uricosuric agents].
    Zöllner N, Gröbner W.
    Arzneimittelforschung; 1971 Oct 14; 21(10):1500-3. PubMed ID: 5171869
    [No Abstract] [Full Text] [Related]

  • 20. [Thyrotoxicosis and benzidarone].
    Camus JP, Prier A, Kartun P, Mauguélis de Bourguesdon.
    Rev Rhum Mal Osteoartic; 1973 Feb 14; 40(2):148-50. PubMed ID: 4705339
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.